Does the HIV-1 manipulate immune network via gp120 immunoglobulin-like domain involving V3 loop?

By Metlas R.   Veljkovic V.  

Vaccine, Vol. 13, Iss. 4, 1995-01 ,pp. : 355-359

Elsevier

Access to resources Recommend Favorite

A new epitope presenting system displays a HIV-1 V3 loop sequence and induces neutralizing antibodies

By Scodeller E.A.   Tisminetzky S.G.   Porro F.   Schiappacassi M.   Baralle F.E.   De Rossi A.   Chiecco-Bianchi L.  

Vaccine, Vol. 13, Iss. 13, 1995-01 ,pp. : 1233-1239

Elsevier

Access to resources Recommend Favorite

Mucosal administration of a chimera composed of Pseudomonas exotoxin and the gp120 V3 loop sequence of HIV-1 induces both salivary and serum antibody responses

By Mrsny R.J.   Daugherty A.L.   Fryling C.M.   FitzGerald D.J.  

Vaccine, Vol. 17, Iss. 11, 1999-03 ,pp. : 1425-1433

Elsevier

Access to resources Recommend Favorite

A V3 loop haptenic peptide sequence, when tandemly repeated, enhances immunogenicity by facilitating helper T-cell responses to a covalently linked carrier protein

By Oscherwitz J.   Zeigler M.E.   Gribbin T.E.   Cease K.B.  

Vaccine, Vol. 17, Iss. 19, 1999-05 ,pp. : 2392-2399

Elsevier

Access to resources Recommend Favorite

Broadly reactive antibodies against a gp120 V3 loop multi-epitope polypeptide neutralize different isolates of human immunodeficiency virus type 1 (HIV-1)

By Montero M.   Menendez A.   del Carmen Dominguez M.   Navea L.   Vilarubia O.L.   Quintana D.   Izquierdo M.   Jimenez V.   Reyes O.   Lobaina L.   Noa E.   Duarte C.A.  

Vaccine, Vol. 15, Iss. 11, 1997-08 ,pp. : 1200-1208

Elsevier

Access to resources Recommend Favorite